checkAd

     157  0 Kommentare Inventiva announces temporary trading halt of its ordinary shares on Euronext Paris - Seite 4

    France

    The ADSs and the ordinary shares have not been and will not be offered or sold to the public in the Republic of France, and no offering of this prospectus or any marketing materials relating to the ADSs and the ordinary shares may be made available or distributed in any way that would constitute, directly or indirectly, an offer to the public in the Republic of France (except for public offerings defined in Article L.411-2 1° of the French Code monétaire et financier).

    The ordinary shares in the form of ADSs may only be offered or sold in France pursuant to article L. 411-1 of the French Code monétaire et financier to qualified investors (investisseurs qualifiés) (as such term is defined in Article 2(e) of Regulation (EU) n° 2017/1129 dated 14 June 2017, as amended) acting for their own account, and in accordance with articles L. 411-1, L. 411-2 and D. 411-2 to D.411-4, D.744-1 and D. 754-1 and D. 764-1 of the French Code monétaire et financier.

    This announcement is not an advertisement and not a prospectus within the meaning of the Prospectus Regulation.

    Contacts

    Inventiva
    Frédéric Cren
    Chairman & CEO
    info@inventivapharma.com
    +33 3 80 44 75 00

    Brunswick Group
    Yannick Tetzlaff /
    Tristan Roquet Montegon /
    Aude Lepreux
    Media relations
    inventiva@brunswickgroup.com
    +33 1 53 96 83 83

    Westwicke, an ICR Company
    Patricia L. Bank
    Investor relations
    patti.bank@westwicke.com
    +1 415 513-1284


    Attachment


    Seite 4 von 4



    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Inventiva announces temporary trading halt of its ordinary shares on Euronext Paris - Seite 4 Daix (France), July 10, 2020 – INVENTIVA S.A. (Euronext Paris: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic …

    Schreibe Deinen Kommentar

    Disclaimer